Segmentation by Mechanism of Action: Delineating the Next Generation Immunology Drug Market Segment Landscape
  The Next Generation Immunology Drug Market segment is fundamentally categorized by the therapeutic mechanism of action (MoA), reflecting the market's technological specialization. The dominant segment remains Monoclonal Antibodies (mAbs), which includes drugs targeting specific cytokines (like IL-17, IL-23, and IL-4/IL-13) or co-stimulatory molecules (like CTLA-4 or CD20). This segment...
0 Comments 0 Shares 49 Views 0 Reviews